Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.
Freyer G, Floquet A, Tredan O, Carrot A, Langlois-Jacques C, Lopez J, Selle F, Abdeddaim C, Leary A, Dubot-Poitelon C, Fabbro M, Gladieff L, Lamuraglia M.
Freyer G, et al. Among authors: lamuraglia m.
Nat Commun. 2024 Mar 5;15(1):1985. doi: 10.1038/s41467-024-45974-w.
Nat Commun. 2024.
PMID: 38443333
Free PMC article.
Clinical Trial.